Dollars for Docs
How Industry Dollars Reach Your Doctors
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
DANIEL LEBOVIC
Listed Specialty: Medical Oncology
19229 MACK AVE, SUITE 24, GROSSE POINTE WOODS, MI, 48236-2858
DANIEL LEBOVIC,
Yearly Payment Breakdown:
2018 Payments At a Glance
86
payments
$64,385
payment total
20
companies paid this doctor
Payment Calendar in 2018
This doctor received a payment on days in 2018.
Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.
2018
Types of Payments in 2018
Category | Payments | Payment Value |
---|---|---|
Promotional Speaking/Other |
24 | $56,918 |
Consulting |
2 | $5,500 |
Food and Beverage |
56 | $1,359 |
Travel and Lodging |
4 | $608 |
Drugs & Devices in 2018
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
Product Name | Product Type | Payments† |
---|---|---|
NINLARO |
drug |
$27,712 |
REVLIMID |
drug |
$20,493 |
KYPROLIS |
drug |
$9,884 |
Payments with no listed product |
N/A |
$5,716 |
IMBRUVICA |
drug |
$188 |
DARZALEX |
drug |
$111 |
VENCLEXTA |
drug |
$48 |
BLINCYTO |
drug |
$48 |
VYXEOS |
drug |
$40 |
XARELTO |
drug |
$31 |
ABRAXANE |
drug |
$31 |
SOLIRIS |
drug |
$31 |
BAVENCIO |
drug |
$20 |
FASLODEX |
drug |
$19 |
HALAVEN |
drug |
$17 |
GAUCHER-DISEASE |
drug |
$16 |
POMALYST |
drug |
$16 |
FOLOTYN |
drug |
$14 |
TAGRISSO |
drug |
$13 |
JEVTANA |
drug |
$13 |
PROSTATE CANCER - DISEASE |
drug |
$13 |
XTANDI |
drug |
$13 |
MEKINIST |
drug |
$12 |
TAFINLAR |
drug |
$12 |
IMLYGIC |
drug |
$12 |
INLYTA |
drug |
$11 |
SUTENT |
drug |
$11 |
LYNPARZA |
drug |
$11 |
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. |
Payment Details in 2018
When | How Much | Related To | What For | From | Third Party Payee |
---|---|---|---|---|---|
May 10, 2018 | $3,850 | NINLARO | Promotional Speaking/Other | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Apr 12, 2018 | $3,850 | NINLARO | Promotional Speaking/Other | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Jan 31, 2018 | $3,850 | NINLARO | Promotional Speaking/Other | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Jun 26, 2018 | $3,000 | KYPROLIS | Promotional Speaking/Other | AMGEN INC. | |
Oct 16, 2018 | $3,000 | KYPROLIS | Promotional Speaking/Other | AMGEN INC. | |
Jan 30, 2018 | $2,750 | NINLARO | Promotional Speaking/Other | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Apr 19, 2018 | $2,750 | NINLARO | Promotional Speaking/Other | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Jun 14, 2018 | $2,750 | NINLARO | Consulting | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Jun 26, 2018 | $2,750 | NINLARO | Promotional Speaking/Other | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Jul 2, 2018 | $2,750 | No Listed Product | Promotional Speaking/Other | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Sep 13, 2018 | $2,750 | No Listed Product | Promotional Speaking/Other | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Apr 26, 2018 | $2,750 | NINLARO | Consulting | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Feb 20, 2018 | $2,695 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Apr 30, 2018 | $2,695 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Feb 22, 2018 | $2,400 | KYPROLIS | Promotional Speaking/Other | AMGEN INC. | |
Sep 20, 2018 | $1,998 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Mar 20, 2018 | $1,978 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Apr 30, 2018 | $1,978 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Mar 26, 2018 | $1,978 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Feb 20, 2018 | $1,978 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Mar 26, 2018 | $1,925 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Oct 18, 2018 | $1,925 | NINLARO | Promotional Speaking/Other | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Mar 20, 2018 | $1,925 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Nov 20, 2018 | $875 | KYPROLIS | Promotional Speaking/Other | AMGEN INC. | |
Sep 20, 2018 | $770 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Oct 16, 2018 | $500 | KYPROLIS | Promotional Speaking/Other | AMGEN INC. | |
Apr 30, 2018 | $263 | REVLIMID | Travel and Lodging | CELGENE CORPORATION | |
Apr 19, 2018 | $123 | NINLARO | Food and Beverage | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Mar 26, 2018 | $122 | REVLIMID | Travel and Lodging | CELGENE CORPORATION | |
Jan 31, 2018 | $114 | NINLARO | Travel and Lodging | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Jan 31, 2018 | $114 | NINLARO | Food and Beverage | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Oct 16, 2018 | $109 | KYPROLIS | Travel and Lodging | AMGEN INC. | |
Sep 20, 2018 | $105 | REVLIMID | Food and Beverage | CELGENE CORPORATION | |
Apr 19, 2018 | $101 | No Listed Product | Food and Beverage | BIOGEN, INC. | |
Jan 30, 2018 | $100 | NINLARO | Food and Beverage | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Sep 13, 2018 | $91 | No Listed Product | Food and Beverage | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Apr 17, 2018 | $85 | REVLIMID | Food and Beverage | CELGENE CORPORATION | |
May 1, 2018 | $28 | IMBRUVICA DARZALEX | Food and Beverage | JANSSEN BIOTECH, INC. | |
Apr 3, 2018 | $26 | DARZALEX IMBRUVICA | Food and Beverage | JANSSEN BIOTECH, INC. | |
May 25, 2018 | $23 | BLINCYTO | Food and Beverage | AMGEN INC. | |
Jun 12, 2018 | $22 | XARELTO | Food and Beverage | JANSSEN PHARMACEUTICALS, INC | |
Oct 19, 2018 | $21 | VYXEOS | Food and Beverage | JAZZ PHARMACEUTICALS INC. | |
Mar 9, 2018 | $20 | VYXEOS | Food and Beverage | JAZZ PHARMACEUTICALS INC. | |
Apr 9, 2018 | $19 | FASLODEX | Food and Beverage | ASTRAZENECA PHARMACEUTICALS LP | |
Sep 18, 2018 | $18 | DARZALEX IMBRUVICA | Food and Beverage | JANSSEN BIOTECH, INC. | |
May 21, 2018 | $17 | SOLIRIS | Food and Beverage | ALEXION PHARMACEUTICALS, INC. | |
Feb 17, 2018 | $17 | HALAVEN | Food and Beverage | EISAI INC. | |
Jan 5, 2018 | $16 | GAUCHER-DISEASE | Food and Beverage | GENZYME CORPORATION | |
Jun 7, 2018 | $16 | DARZALEX IMBRUVICA | Food and Beverage | JANSSEN BIOTECH, INC. | |
Feb 6, 2018 | $14 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Apr 9, 2018 | $14 | SOLIRIS | Food and Beverage | ALEXION PHARMACEUTICALS, INC. | |
Oct 23, 2018 | $14 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Mar 14, 2018 | $14 | NINLARO | Food and Beverage | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Oct 10, 2018 | $14 | FOLOTYN | Food and Beverage | SPECTRUM PHARMACEUTICALS INC. | |
Jun 8, 2018 | $13 | TAGRISSO | Food and Beverage | ASTRAZENECA PHARMACEUTICALS LP | |
Nov 20, 2018 | $13 | JEVTANA PROSTATE CANCER - DISEASE | Food and Beverage | GENZYME CORPORATION | |
Nov 16, 2018 | $13 | BLINCYTO | Food and Beverage | AMGEN INC. | |
Dec 10, 2018 | $13 | VENCLEXTA | Food and Beverage | ABBVIE, INC. | |
Jun 26, 2018 | $13 | VENCLEXTA | Food and Beverage | ABBVIE, INC. | |
Apr 25, 2018 | $13 | XTANDI | Food and Beverage | MEDIVATION FIELD SOLUTIONS LLC | |
Jul 20, 2018 | $13 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Mar 21, 2018 | $12 | MEKINIST TAFINLAR | Food and Beverage | NOVARTIS PHARMACEUTICALS CORPORATION | |
May 15, 2018 | $12 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Nov 28, 2018 | $12 | DARZALEX IMBRUVICA | Food and Beverage | JANSSEN BIOTECH, INC. | |
Aug 15, 2018 | $12 | No Listed Product | Food and Beverage | GILEAD SCIENCES INC | |
Sep 28, 2018 | $12 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Dec 26, 2018 | $12 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Sep 14, 2018 | $12 | ABRAXANE | Food and Beverage | CELGENE CORPORATION | |
Jun 6, 2018 | $12 | ABRAXANE | Food and Beverage | CELGENE CORPORATION | |
Nov 28, 2018 | $12 | No Listed Product | Food and Beverage | GILEAD SCIENCES INC | |
May 25, 2018 | $12 | BLINCYTO IMLYGIC | Food and Beverage | AMGEN INC. | |
Oct 15, 2018 | $11 | VENCLEXTA | Food and Beverage | ABBVIE, INC. | |
Jul 11, 2018 | $11 | SUTENT INLYTA BAVENCIO | Food and Beverage | PFIZER INC. | |
Feb 27, 2018 | $11 | VENCLEXTA | Food and Beverage | ABBVIE, INC. | |
Dec 12, 2018 | $11 | LYNPARZA | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
Jul 18, 2018 | $10 | NINLARO | Food and Beverage | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Sep 4, 2018 | $10 | DARZALEX IMBRUVICA | Food and Beverage | JANSSEN BIOTECH, INC. | |
Mar 6, 2018 | $9 | XARELTO | Food and Beverage | JANSSEN PHARMACEUTICALS, INC | |
Aug 22, 2018 | $8 | BAVENCIO | Food and Beverage | EMD SERONO, INC. | |
Sep 4, 2018 | $8 | POMALYST | Food and Beverage | CELGENE CORPORATION | |
Mar 6, 2018 | $8 | ABRAXANE | Food and Beverage | CELGENE CORPORATION | |
Dec 14, 2018 | $8 | POMALYST | Food and Beverage | CELGENE CORPORATION | |
Oct 30, 2018 | $7 | NINLARO | Food and Beverage | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Oct 11, 2018 | $5 | NINLARO | Food and Beverage | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
May 1, 2018 | $2 | IMBRUVICA DARZALEX | Food and Beverage | JANSSEN BIOTECH, INC. | |
Jun 12, 2018 | $0 | XARELTO | Food and Beverage | JANSSEN PHARMACEUTICALS, INC |
See this doctor’s Open Payments page →
Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].
This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.